Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1220 publications
Nonmyeloablative Pentostatin-Cyclophosphamide Preconditioning Improves Rates of Engraftment in Adults Undergoing Haploidentical HCT for Sickle Cell Disease.
Journal: medRxiv : the preprint server for health sciences
Published: September 15, 2025
Threading through the data for chemotherapy-free alternatives in the treatment of hairy cell leukemia.
Journal: Leukemia & lymphoma
Published: September 01, 2025
8-OXO-Cordycepin Is Not a Suitable Substrate for Adenosine Deaminase-Preliminary Experimental and Theoretical Studies.
Journal: Molecules (Basel, Switzerland)
Published: July 07, 2025
Exploring adenosine analogs for chondrosarcoma therapy: In vitro and in vivo insights.
Journal: Molecular therapy. Nucleic acids
Published: June 02, 2025
Structural basis of substrate specificity of Helix pomatia AMP deaminase and a chimeric ADGF adenosine deaminase.
Journal: bioRxiv : the preprint server for biology
Published: April 08, 2025
Structural basis for the substrate specificity of Helix pomatia AMP deaminase and a chimeric ADGF adenosine deaminase.
Journal: The Journal of biological chemistry
Published: March 31, 2025
Enhanced Antioxidant and Anti-inflammatory Properties of Albino Cordyceps militaris: A Comparative Study With Wild-type Strain.
Journal: Chemistry & biodiversity
Published: March 29, 2025
B Cell Activating Factor Induces Drug Resistance in Hairy Cell Leukemia Variant.
Journal: Biomedicines
Published: February 23, 2025
Constructing a mitochondrial-related genes model based on machine learning for predicting the prognosis and therapeutic effect in colorectal cancer.
Journal: Discover oncology
Published: February 11, 2025
Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myeloma.
Journal: Journal for immunotherapy of cancer
Published: January 15, 2025
Two Nonmyeloablative HLA-Matched Related Donor Allogeneic Hematopoietic Cell Transplantation Regimens in Patients with Severe Sickle Cell Disease.
Journal: Transplantation and cellular therapy
Published: December 12, 2024
Last Updated: 10/31/2025